DE2543994C3 - Proteinmodifizierte Verbindungen des schwangerschaftsspezifischen ß, -Glykoproteins und deren Verwendung als Bestandteil von immunisierenden Mitteln - Google Patents

Proteinmodifizierte Verbindungen des schwangerschaftsspezifischen ß, -Glykoproteins und deren Verwendung als Bestandteil von immunisierenden Mitteln

Info

Publication number
DE2543994C3
DE2543994C3 DE2543994A DE2543994A DE2543994C3 DE 2543994 C3 DE2543994 C3 DE 2543994C3 DE 2543994 A DE2543994 A DE 2543994A DE 2543994 A DE2543994 A DE 2543994A DE 2543994 C3 DE2543994 C3 DE 2543994C3
Authority
DE
Germany
Prior art keywords
pregnancy
specific
glycoprotein
protein
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2543994A
Other languages
German (de)
English (en)
Other versions
DE2543994B2 (de
DE2543994A1 (de
Inventor
Hans Dr. 3550 Marburg Bohn
Ernst Dr. 3551 Michelbach Weinmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DE2543994A priority Critical patent/DE2543994C3/de
Priority to NL7610688A priority patent/NL7610688A/xx
Priority to IL50589A priority patent/IL50589A/xx
Priority to FI762790A priority patent/FI762790A7/fi
Priority to SE7610892A priority patent/SE7610892L/xx
Priority to LU75913A priority patent/LU75913A1/xx
Priority to IT27866/76A priority patent/IT1070582B/it
Priority to NZ182193A priority patent/NZ182193A/xx
Priority to DK444576A priority patent/DK444576A/da
Priority to AT731176A priority patent/AT352756B/de
Priority to NO763361A priority patent/NO763361L/no
Priority to AU18318/76A priority patent/AU511175B2/en
Priority to JP11795476A priority patent/JPS5290613A/ja
Priority to FR7629798A priority patent/FR2326203A1/fr
Priority to GB41042/76A priority patent/GB1560633A/en
Priority to BE171227A priority patent/BE846928A/xx
Publication of DE2543994A1 publication Critical patent/DE2543994A1/de
Priority to FI783925A priority patent/FI783925A7/fi
Publication of DE2543994B2 publication Critical patent/DE2543994B2/de
Application granted granted Critical
Publication of DE2543994C3 publication Critical patent/DE2543994C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE2543994A 1975-10-02 1975-10-02 Proteinmodifizierte Verbindungen des schwangerschaftsspezifischen ß, -Glykoproteins und deren Verwendung als Bestandteil von immunisierenden Mitteln Expired DE2543994C3 (de)

Priority Applications (17)

Application Number Priority Date Filing Date Title
DE2543994A DE2543994C3 (de) 1975-10-02 1975-10-02 Proteinmodifizierte Verbindungen des schwangerschaftsspezifischen ß, -Glykoproteins und deren Verwendung als Bestandteil von immunisierenden Mitteln
NL7610688A NL7610688A (nl) 1975-10-02 1976-09-27 Derivaten van het voor zwangerschap specifieke (beta)-glycoproteine, werkwijze voor het bereiden daarvan en van deze derivaten bevattende mid- delen.
FI762790A FI762790A7 (enExample) 1975-10-02 1976-09-30
SE7610892A SE7610892L (sv) 1975-10-02 1976-09-30 Derivat av det havandeskapsspecifika beta?711-glykoproteinet, forfarande for deras framstellning och medel, som innehaller dessa derivat
LU75913A LU75913A1 (enExample) 1975-10-02 1976-09-30
IT27866/76A IT1070582B (it) 1975-10-02 1976-09-30 Derivati della e,glicoproteina specifica della gravidanza processi per la loro preparazione e mezzi che li contengono
NZ182193A NZ182193A (en) 1975-10-02 1976-09-30 Derivatives of the pregnancyspecific -glycoprotein,and immunising agents
IL50589A IL50589A (en) 1975-10-02 1976-09-30 Derivatives of the pregnancyspecific -glycoprotein,process for their manufacture and agents containing them
DK444576A DK444576A (da) 1975-10-02 1976-10-01 Derivater af svangerskabsspecifikt beta1-glykoprotein fremgangsmade til deres fremstilling og midler indeholdende disse
AT731176A AT352756B (de) 1975-10-02 1976-10-01 Verfahren zur verstaerkung der antigenen wirkung des schwangerschaftsspezifischen beta1- glykoproteins
NO763361A NO763361L (enExample) 1975-10-02 1976-10-01
AU18318/76A AU511175B2 (en) 1975-10-02 1976-10-01 Derivatives ofthe pregnancy-specific Bi-glycoprotein
JP11795476A JPS5290613A (en) 1975-10-02 1976-10-02 Pregnancyypeculiar beta11glycoprotein derivative
GB41042/76A GB1560633A (en) 1975-10-02 1976-10-04 Derivatives of the pregnancy-specific 1-glycoprotein and process for their manufacture
FR7629798A FR2326203A1 (fr) 1975-10-02 1976-10-04 Derives de la b1-glycoproteine specifique de la grossesse, leur preparation et leurs applications
BE171227A BE846928A (fr) 1975-10-02 1976-10-04 Derives de la bi-glycoproteine specifique de la grossesse, leur preparation et leurs applications
FI783925A FI783925A7 (fi) 1975-10-02 1978-12-20 Foerfarande foer framstaellning av derivat av foer havandeskap specifikt beta1-glykoprotein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2543994A DE2543994C3 (de) 1975-10-02 1975-10-02 Proteinmodifizierte Verbindungen des schwangerschaftsspezifischen ß, -Glykoproteins und deren Verwendung als Bestandteil von immunisierenden Mitteln

Publications (3)

Publication Number Publication Date
DE2543994A1 DE2543994A1 (de) 1977-04-07
DE2543994B2 DE2543994B2 (de) 1979-02-15
DE2543994C3 true DE2543994C3 (de) 1979-10-11

Family

ID=5958064

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2543994A Expired DE2543994C3 (de) 1975-10-02 1975-10-02 Proteinmodifizierte Verbindungen des schwangerschaftsspezifischen ß, -Glykoproteins und deren Verwendung als Bestandteil von immunisierenden Mitteln

Country Status (16)

Country Link
JP (1) JPS5290613A (enExample)
AT (1) AT352756B (enExample)
AU (1) AU511175B2 (enExample)
BE (1) BE846928A (enExample)
DE (1) DE2543994C3 (enExample)
DK (1) DK444576A (enExample)
FI (1) FI762790A7 (enExample)
FR (1) FR2326203A1 (enExample)
GB (1) GB1560633A (enExample)
IL (1) IL50589A (enExample)
IT (1) IT1070582B (enExample)
LU (1) LU75913A1 (enExample)
NL (1) NL7610688A (enExample)
NO (1) NO763361L (enExample)
NZ (1) NZ182193A (enExample)
SE (1) SE7610892L (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191533A (en) * 1971-09-29 1980-03-04 Behringwerke Aktiengesellschaft Pregnancy-specific β1 -glycoprotein and process for isolating it
DE3525926A1 (de) 1985-07-19 1987-01-29 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung von pankreas-alpha-amylase
EP2814499A4 (en) * 2012-02-17 2015-10-21 Castech Lab Llc PURIFICATION PROCESS

Also Published As

Publication number Publication date
AU1831876A (en) 1978-04-06
DK444576A (da) 1977-04-03
FR2326203A1 (fr) 1977-04-29
DE2543994B2 (de) 1979-02-15
DE2543994A1 (de) 1977-04-07
FI762790A7 (enExample) 1977-04-03
IL50589A0 (en) 1976-11-30
ATA731176A (de) 1979-03-15
AU511175B2 (en) 1980-07-31
FR2326203B1 (enExample) 1980-10-31
LU75913A1 (enExample) 1977-05-11
BE846928A (fr) 1977-04-04
NZ182193A (en) 1979-03-28
AT352756B (de) 1979-10-10
SE7610892L (sv) 1977-04-03
IL50589A (en) 1980-10-26
JPS5290613A (en) 1977-07-30
NL7610688A (nl) 1977-04-05
IT1070582B (it) 1985-03-29
GB1560633A (en) 1980-02-06
NO763361L (enExample) 1977-04-05

Similar Documents

Publication Publication Date Title
DE3881281T2 (de) Stabilisierter attenuierter lebender impfstoff und seine herstellung.
DE69232617T2 (de) Gefriergetrocknete Zubereitung, die einen monoklonalen Antikörper enthält
DE69230733T3 (de) Teil der konstanten region von ige enthaltender impfstoff zur behandlung ige-induzierter allergischer reaktionen
DE2433883C2 (de) Verwendung von physiologisch aktiven Polypeptiden
US3591574A (en) Tri-n-phenylglycyl derivatives of insulin
DE2128670B2 (de) Immunologische isoenzym-bestimmungsmethode
Pourcho et al. Immunocytochemical demonstration of glycine in retina
DE2848529A1 (de) Verfahren zur herstellung des kaelteunloeslichen globulins und dieses enthaltende arzneimittel
DE2648759C3 (de) Stabilisierungsmittel für Enzyme
EP0001443B1 (de) Mittel zur Konzeptionsverhütung und Schwangerschaftsunterbrechung bei Primaten und Verfahren zu ihrer Herstellung
DE2543994C3 (de) Proteinmodifizierte Verbindungen des schwangerschaftsspezifischen ß, -Glykoproteins und deren Verwendung als Bestandteil von immunisierenden Mitteln
DE3224217A1 (de) Enzymimmunoassay-methode zur qualitativen und quantitativen bestimmung von substanzen
DE2508132B2 (de) Verfahren zur Herstellung von HumaninununglobuUn-Derivaten und parenteral applizierbare Lösung hiervon
DE3236264A1 (de) Verfahren zur gewinnung von relaxin
EP0209155A1 (de) Konjugat für die Enzymimmunobestimmung
EP0287076A1 (de) Rezeptor der Kleinen Rhinovirus Rezeptor Gruppe
CH622426A5 (en) Contraceptive composition
DE1940130C2 (de) Verfahren zur Reinigung von Insulin, nach diesem Verfahren gereinigtes Insulin und dessen Verwendung
DE69738017T2 (de) Verfahren und verwendung eines polypeptids in der sperma-eizellen-bindung zur erhöhung oder verringerung der fertilität
DE1902865A1 (de) Substituierte Insulin-Derivate,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
Siess et al. A simple method for the preparation of pure and active gamma-globulin-ferritin conjugates using glutaraldehyde
DE3511327A1 (de) Stabilisierung der aktivitaet von peroxidase in loesung
Wittle et al. Toxic and immunological properties of stinging coral toxin
DE2646223C2 (enExample)
DE2924332A1 (de) Flavin-adenin-dinukleotid-markiertes konjugat und dessen verwendung in spezifischen bindungsversuchen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee